Factors contributing to the risk of cardiovascular disease reflected by plasma adiponectin. Data from the coronary risk factors for atherosclerosis in women (CORA) study

Atherosclerosis

Volumn 200, Issue 2, 2008, Pages 403-409

  Zyriax, Birgit Christiane ^a   Algenstaedt, Petra ^a   Hess, Utz Florian ^a   Schöffauer, Mark ^b   Bamberger, Christoph ^a   Boeing, Heiner ^c   Windler, Eberhard ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Adiponectin; Central adiposity; Coronary heart disease; Metabolic syndrome; Risk factor

Indexed keywords

ADIPONECTIN; ALCOHOL; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIETARY INTAKE; FEMALE; FRUIT; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEAT; NUTRITION; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; VEGETABLE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPONECTIN; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BODY MASS INDEX; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 52149083941     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.033     Document Type: Article

References (37)

1. Hoffmann K., Zyriax B.C., Boeing H., and Windler E. A dietary pattern derived to explain biomarker variation is strongly associated with the risk of coronary artery disease. Am J Clin Nutr 80 (2004) 633-640
2. Zyriax B.C., Boeing H., and Windler E. Nutrition is a powerful independent risk factor for coronary heart disease in women-the CORA study: a population-based case-control study. Eur J Clin Nutr 59 (2005) 1201-1207
3. Gable D.R., Hurel S.J., and Humphries S.E. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 188 (2006) 231-244
4. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
5. Im J.A., Kim S.H., Lee J.W., et al. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults. Metabolism 55 (2006) 1546-1550
6. Imbeault P. Environmental influences on adiponectin levels in humans. Appl Physiol Nutr Metab 32 (2007) 505-511
7. Rothenbacher D., Brenner H., Marz W., and Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 26 (2005) 1640-1646
8. Stefan N., Vozarova B., Funahashi T., et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51 (2002) 1884-1888
9. Kantartzis K., Rittig K., Balletshofer B., et al. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem 52 (2006) 1934-1942
10. Ouchi N., and Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380 (2007) 24-30
11. Fruebis J., Tsao T.S., Javorschi S., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98 (2001) 2005-2010
12. Kumada M., Kihara S., Sumitsuji S., et al., Osaka CAD Study Group. Association of hypoadiponectinemia with coronary heart diseases in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
13. Pischon T., Girman C.J., Hotamisligil G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
14. Pilz S.., et al. Adiponectin serum concentrations in men with coronary artery disease: The LUdwigshafen RIsk and Cardiovascular Health (LURIC) Study. Clin Chim Acta 364 (2006) 251-255
15. Lawlor D.A., Davey Smith G., Ebrahim S., Thompson C., and Sattar N. Plasma adiponectin levels are associated with insulin resistance but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 90 (2005) 5677-5683
16. Pilz S., Mangge H., Wellnitz B., et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 91 (2006) 4277-4286
17. Hajer G.R., van der Graaf Y., Olijhoek J.K., et al. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease. Am Heart J 154 (2007) 750.e1-750.e7
18. Bohlscheid T.S., Hoting I., Boeing H., and Wahrendorf J. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German Part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1 Suppl. 26 (1997) S59-S70
19. Kroke A., Klipstein-Grobusch K., Voss S., et al. Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. Am J Clin Nutr 70 (1999) 439-447
20. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
21. Marques-Vidal P., Mazoyer E., Bongard V., et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25 (2002) 1371-1377
22. Chobanian A.V., Bakris G.L., Black H.R., et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 89 (2003) 2560-2571
23. Hu F.B., and Willett W.C. Optimal diets for prevention of coronary heart disease. JAMA 288 (2002) 2569-2578
24. Panagiotakos D.B., Pitsavos C., Kokkinos P., et al. Consumption of fruits and vegetables in relation to the risk of developing acute coronary syndromes; the CARDIO2000 case-control study. Nutr J 2 (2003) 2
25. Kontogianni M.D., Panagiotakos D.B., Pitsavos C., Chrysohoou C., and Stefanadis C. Relationship between meat intake and the development of acute coronary syndromes: the CARDIO2000 case-control study. Eur J Clin Nutr (2007) 10.1038/sj.ejcn.1602713
26. Qi L., Meigs J.B., Liu S., et al. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care 29 (2006) 1501-1505
27. Iwashima Y., Katsuya T., Ishikawa K., et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension 45 (2005) 1094-1100
28. Baratta R., Amato S., Degano C., et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metabol 89 (2004) 2665-2671
29. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., and Ranganathan G. Adiponectin expression from human adipose tissue-relation to obesity, insulin resistance, and tumor necrosis factor-expression. Diabetes 52 (2003) 1779-1785
30. Kazumi T., Kawaguchi A., Sakai K., Hirano T., and Yoshino G. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25 (2002) 971-976
31. Adamczak M., Wiecek A., Funahashi T., et al. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16 (2003) 72-75
32. Huang K.C., Chen C.L., Chuang L.M., et al. Plasma adiponectin levels and blood pressure in nondiabetic adolescent females. J Clin Endocrinol Metabol 88 (2003) 4130-4134
33. Yang W.S., Lee W.J., Funahashi T., et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 10 (2002) 1104-1110
34. Maahs D.M., Ogden L.G., Kinney G.L., et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111 (2005) 747-753
35. Rathmann W., and Herder C. Adiponectin and cardiovascular mortality: evidence for "Reverse Epidemiology". Horm Metab Res 39 (2007) 1-2
36. Inoue T., Kotooka N., Morooka T., et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 100 (2007) 569-574
37. Komaba H., Igaki N., Goto S., et al. Increased serum high-molecular-weight complex of adiponectin in type 2 diabetic patients with impaired renal function. Am J Nephrol 26 (2006) 476-482